Welcome to Macroaxis
Sign in to go to your portfolios
Don't have an account? Create It
  Macroaxis: Personalized Investing   The proven technology to invest wisely
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
  
 
US Market Closed: May 26, 20:00 PM 2012  
HLF AUXL PBH USNA LFVN NUTR 
 
 
  NYSE  7,534  18.032  Index Moved Down 



Processing
Collecting data for PRGO

Perrigo management performance

    
    

Perrigo

 Stock@American Stock Exchange 
United States
    
Use Perrigo management performance together with your assets to enhance returns of your portfolios as well as to check it against diversification policy that fits your risk preferences.
    
    

Perrigo Management Effectiveness

The company has return on total asset (ROA) of 10.01 % which means that it generated profit of $10.01 on every $1 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 23.24 % meaning that it created $23.24 on every dollar invested by stockholders.

Perrigo Profit Margins

The company has Profit Margin (PM) of 12.2 % which can be a sign that it executes well on its competitive strategies and has a good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 18.61 % which suggests for every dolor of sales it generated a net operating income of 0.19.

Perrigo Insiders

    
Joseph Papa Chairman, CEO and Pres
Scott Jamison Executive Vice President General Manager - Nutritionals
Jeffrey Needham Executive Vice President General Manager - Consumer Healthcare
Todd Kingma Executive Vice president, Secretary and General Counsel
Michael Stewart Senior Vice President - Global Human Resources
Refael Lebel Executive VP and President of Perrigo Israel
Thomas Farrington Senior Vice President CIO
Sharon Kochan Executive Vice President General Manager - Rx Pharmaceuticals
Louis Yu Senior Vice President - Global Quality and Compliance, Ph.D
Jatin Shah Chief Scientific Officer, Senior Vice President, Ph.D
Judy Brown CFO, Chief Accounting Officer and Executive VP
John Hendrickson Executive VP of Global Operations and Supply Chain
Herman Morris Independent Director
Gary Kunkle Lead Independent Director
Gary Cohen Independent Director
Ben-Zion Zilberfarb Independent Director
Ellen Hoffing Independent Director
Michael Jandernoa Independent Director
Laurie Brlas Independent Director
Ran Gottfried Independent Director
David Gibbons Independent Director
    

Perrigo Workforce

    
Perrigo is considered to be number one stock in number of employees category among related companies. The total workforce of Drug Related Products industry is at this time estimated at about 16,695. Perrigo totals roughly 8,660 in number of employees claiming about 52% of equities under Drug Related Products industry.
    
    
Joseph Papa  Chairman
Chairman, CEO and Pres
Mr. Joseph C. Papa is Chairman of the Board, President, Chief Executive Officer of Perrigo Company. He joined Perrigo in October 2006 as President and Chief Executive Officer, was elected to the Board of Directors in Nov...
Scott Jamison  President
Executive Vice President General Manager - Nutritionals
Mr. Scott F. Jamison is Executive Vice President, General Manager Nutritionals of Perrigo Company., since January 2011. Before the Company acquired PBM in fiscal 2010, Mr. Jamison had served as PBM Executive Vice Preside...
    

Tenure Analysis

Perrigo employes about 8660 people. The company is managed by 21 executives with total tenure of roughly 118 years, averanging almost 5.0 years of service per executive having 412.0 employee per reported executive.

Return on Perrigo Manpower

Revenue Per Employee 352.2 K
Revenue Per Executive 145.2 M
Net Income Per Employee 42.9 K
Net Income Per Executive 17.7 M
Working Capital Per Employee 134.1 K
Working Capital Per Executive 55.3 M

Perrigo Earnings Per Share

According to company disclosure Perrigo has Earnings Per Share of 3.95 times. This is 272.64% higher than that of Healthcare sector, and 456.34% higher than that of Drug Related Products industry, The Earnings Per Share for all stocks is 166.89% lower than the firm.
Earnings per Share is one of the most important measures of current share price of a firm, and is used by investors to determine company overall profitability especially when it is compared to EPS of similar companies.

Discuss Perrigo

    
    



 

 
Analytics
Investor Landscape
Efficient Frontier
Market Correlation
Risk and Return Analysis
Financial Content
Portfolio Projections
Portfolio Backtesting
Tools
FAQs
Retirement Optimizer
RSS and Mobile Access
Company Directory
Advisor Directory
Insider Directory
Wealth Management
About Us
About Macroaxis
Contact Us
Terms Of Use
Privacy Policy
Custom Reporting
Product Tour
More ROI Custom Reporting